Nuwellis (NUWE)
(Delayed Data from NSDQ)
$5.21 USD
-1.40 (-21.18%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $5.21 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NUWE 5.21 -1.40(-21.18%)
Will NUWE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NUWE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NUWE
Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates
CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates
NUWE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates (Revised)
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates
Other News for NUWE
12 Health Care Stocks Moving In Tuesday's Intraday Session
Nuwellis (NUWE) Reaches Milestone with Aquadex Therapy in Outpatient Settings
Nuwellis announces first successful outpatient application of Aquadex Smartflow
12 Health Care Stocks Moving In Monday's Intraday Session